BEUDAMED
    FDA Adverse Event Injury Summary report: N

    BIOFLO VORTEX

    MDR report key: 23618148 · Received November 21, 2025

    Report

    Report Number
    1317056-2025-00336
    Event Type
    Injury
    Date Received
    November 21, 2025
    Date of Event
    December 11, 2023
    Report Date
    March 24, 2026
    Manufacturer
    ANGIODYNAMICS, INC
    Product Code
    LJT
    UDI-DI
    15051684016773
    PMA / PMN Number
    K190559
    Adverse Event
    Yes
    Report Source
    Manufacturer report
    Reporter Location
    OH, US
    Reporter Occupation
    003

    Narratives

    Additional Manufacturer Narrative · 0

    THE DEVICE IS NOT AVAILABLE TO BE RETURNED TO THE MANUFACTURER FOR EVALUATION. AN INVESTIGATION INTO THE ROOT CAUSE FOR THE EVENT IS CURRENTLY IN PROGRESS. THE RESULTS OF THE INVESTIGATION WILL BE SENT VIA A FOLLOW UP MEDWATCH. REFERENCE (B)(4).

    Additional Manufacturer Narrative · 0

    THE CUSTOMER'S REPORTED COMPLAINT DESCRIPTION OF PATIENT INFECTION CANNOT BE CONFIRMED GIVEN THE PATIENT CENTRIC NATURE OF THIS SERIOUS ADVERSE EVENT (SAE). NO PORT DEVICE WAS RETURNED FOR EVALUATION SINCE THERE WAS NO REPORT OF PORT DEVICE MALFUNCTION, DAMAGE OR PERFORMANCE ISSUE DURING USE. A DEVICE HISTORY RECORD (DHR) REVIEW OF THE PACKAGING LOT REVEALED NO QUALITY RELATED ISSUES OR MANUFACTURING DEFICIENCIES AT THE TIME OF MANUFACTURE. STERILIZATION LOAD RELEASE RECORDS WERE REVIEWED FOR THE PACKAGING LOT IN QUESTION; NO ISSUES WERE OBSERVED. THE PORT WAS IMPLANTED INTO THE PATIENT MORE THAN 1 MONTH PRIOR TO THE PATIENT'S INFECTION. THERE WAS NO REPORT OF PORT DEVICE MALFUNCTION OR PERFORMANCE ISSUE DURING USE. IF THE MANUFACTURING/PACKAGING/STERILIZATION OF THE PORT DEVICE IN QUESTION WAS TO CONTRIBUTE TO AN INFECTION IN THE PATIENT IT WOULD HAVE LIKELY OCCURRED SHORTLY AFTER THE IMPLANT DATE AND NOT MORE THAN 1 MONTH LATER. DEVICE DIRECTIONS FOR USE (DFU) CAUTIONS THAT EACH ACCESS OF THE PORT SHOULD BE PERFORMED USING ASEPTIC TECHNIQUE, FOLLOWING THE INSTITUTIONS UNIVERSAL PRECAUTIONS. THERE IS NO INDICATION FROM THE REPORTED COMPLAINT THAT THE MANUFACTURING/PACKAGING/STERILIZATION OF THE PORT DEVICE COULD HAVE CONTRIBUTED TO THE PATIENT'S INFECTION. INFECTION IS CAUTIONED IN THE DEVICE DFU AS A POTENTIAL COMPLICATION OF PORT SYSTEM USE. LABELING REVIEW: THE DIRECTION FOR USE (DFU) PROVIDED WITH THE PORT DEVICE CONTAINS THE FOLLOWING STATEMENTS: CONTRAINDICATIONS: PRESENCE OF INFECTION, BACTEREMIA, OR SEPTICEMIA. WARNINGS: THE DEVICE IS TO BE IMPLANTED, USED, MAINTAINED AND REMOVED IN ACCORDANCE WITH CURRENT EVIDENCE-BASED GUIDANCE FOR INFECTION PREVENTION FROM AGENCIES/ORGANIZATIONS SUCH AS CENTERS OF DISEASE CONTROL (CDC) OR THE WORLD HEALTH ORGANIZATION. IT IS RECOMMENDED THAT INSTITUTIONAL POLICIES AND PROCEDURES ARE UPDATED PERIODICALLY TO REFLECT CURRENT EVIDENCE-BASED GUIDELINES FOR INFECTION PREVENTION. CONTAMINATION OF THE DEVICE MAY LEAD TO INJURY, ILLNESS OR DEATH OF THE PATIENT. PRECAUTIONS: CAREFULLY READ AND FOLLOW ALL INSTRUCTIONS PRIOR TO USE. AFTER IMPLANTATION OR USAGE OF THE PORT, THE SYSTEM SHOULD BE FLUSHED TO CLEAR INFUSATES AND/OR BLOOD COMPONENTS IN ORDER TO MAINTAIN PATENCY. IF MORE THAN ONE DRUG IS TO BE ADMINISTERED, BETWEEN THE INDIVIDUAL DRUG APPLICATIONS, FLUSH THE SYSTEM WITH 5 TO 10 ML NORMAL SALINE FOR INJECTION TO PREVENT DRUG INTERACTION. POTENTIAL COMPLICATIONS: BACTEREMIA, CATHETER THROMBOSIS, CATHETER OR PORT EROSION THROUGH SKIN/VESSEL, DEATH, INFLAMMATION, INFECTION, IMPLANTATION SITE NECROSIS OR SCARRING OF SKIN OVER IMPLANT AREA, THROMBOEMBOLISM, THROMBOPHLEBITIS, TUNNEL INFECTION, VASCULAR THROMBOSIS. USE AND MAINTENANCE AFTER IMPLANTATION OR USAGE OF THE PORT, THE SYSTEM SHOULD BE FLUSHED AND LOCKED TO CLEAR INFUSATES AND/OR BLOOD COMPONENTS IN ORDER TO MAINTAIN PATENCY. A REVIEW OF THE ANGIODYNAMICS COMPLAINT SYSTEM NOTED NO ADVERSE TRENDS FOR THIS COMPLAINT TYPE AND PRODUCT FAMILY. THIS TYPE OF COMPLAINT CONTINUES TO BE MONITORED FOR TRENDS. REFERENCE (B)(4).

    Description of Event or Problem · 0

    ON OR ABOUT (B)(6) 2023, PLAINTIFF (B)(6) UNDERWENT AN INSERTION AN ANGIODYNAMICS SMARTPORT PORT CATHETER PRODUCT, MODEL NUMBER CT80LPBDVI, LOT NUMBER 5804580. UPON INFORMATION AND BELIEF, THIS SMARTPORT DEVICE CONSISTED OF A PORT BODY AND A POLYURETHANE CATHETER. THE SMARTPORT WAS IMPLANTED AT (B)(6) FOR CHEMOTHERAPY TREATMENT. PLAINTIFF AND HIS HEALTH CARE PROVIDERS USED THE SMARTPORT IN A NORMAL, CUSTOMARY, INTENDED, AND FORESEEABLE MANNER, NAMELY AS A SURGICALLY PLACED DEVICE USED TO MAKE IT EASIER TO DELIVER MEDICATIONS DIRECTLY INTO THE PLAINTIFF'S BLOODSTREAM. MOREOVER, PLAINTIFF'S HEALTH CARE PROVIDERS DID NOT PLACE OR MAINTAIN THE DEVICE INCORRECTLY SUCH THAT IT CAUSED THE DEVICE TO "PINCH OFF" OR OTHERWISE MALFUNCTION. ON OR ABOUT (B)(6) 2023, PLAINTIFF PRESENTED TO (B)(6) FOR TREATMENT OF A STAPH BACTEREMIA INFECTION CAUSED BY HIS SMARTPORT DEVICE, THAT WAS CONFIRMED AND DIAGNOSED VIA POSITIVE BLOOD CULTURES, RESULTING IN THE REMOVAL OF THE SMARTPORT DEVICE ON OR ABOUT (B)(6) 2023. THESE INJURIES WERE DIRECTLY AND PROXIMATELY CAUSED BY THE WRONGFUL CONDUCT OF THE DEFENDANTS AND THE UNREASONABLY DANGEROUS AND DEFECTIVE NATURE OF HIS SMARTPORT, AS FURTHER ALLEGED HEREIN.

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    2464321 BIOFLO VORTEX PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR LJT ANGIODYNAMICS, INC H787CT80LPBDVI0 5804580 15051684016773

    Patients

    Seq Age Sex Outcome Treatment
    1 NA Male Required Intervention| H| O